Yumin Wu

1.2k total citations
53 papers, 898 citations indexed

About

Yumin Wu is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Yumin Wu has authored 53 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Yumin Wu's work include IL-33, ST2, and ILC Pathways (12 papers), Nanoplatforms for cancer theranostics (8 papers) and Eosinophilic Esophagitis (7 papers). Yumin Wu is often cited by papers focused on IL-33, ST2, and ILC Pathways (12 papers), Nanoplatforms for cancer theranostics (8 papers) and Eosinophilic Esophagitis (7 papers). Yumin Wu collaborates with scholars based in China, Taiwan and Ghana. Yumin Wu's co-authors include Zhuang Liu, Liangzhu Feng, Huaxi Xu, Shengjun Wang, Qingli Bie, Zhaoliang Su, Ziliang Dong, Chunjie Wang, Hao Yu and Quguang Li and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Yumin Wu

49 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumin Wu China 17 378 282 206 165 120 53 898
Yuyue Zhao China 15 210 0.6× 198 0.7× 246 1.2× 60 0.4× 117 1.0× 31 682
Qingfeng Chen Singapore 14 198 0.5× 179 0.6× 395 1.9× 81 0.5× 152 1.3× 20 825
Zichao Huang China 16 405 1.1× 307 1.1× 409 2.0× 35 0.2× 157 1.3× 45 968
Ziying Fei China 13 254 0.7× 377 1.3× 302 1.5× 37 0.2× 138 1.1× 17 755
Lina Guo China 12 171 0.5× 258 0.9× 272 1.3× 38 0.2× 51 0.4× 17 782
Małgorzata Wachowska Poland 16 265 0.7× 313 1.1× 233 1.1× 43 0.3× 134 1.1× 31 905
Hsuan‐Chen Liu United States 14 155 0.4× 131 0.5× 189 0.9× 88 0.5× 245 2.0× 23 644
Pengfei Zhao China 13 196 0.5× 219 0.8× 342 1.7× 33 0.2× 170 1.4× 21 810
Xiaowen Tong China 20 100 0.3× 113 0.4× 363 1.8× 139 0.8× 168 1.4× 69 920
Yujie Su China 19 151 0.4× 397 1.4× 313 1.5× 121 0.7× 59 0.5× 44 978

Countries citing papers authored by Yumin Wu

Since Specialization
Citations

This map shows the geographic impact of Yumin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Wu more than expected).

Fields of papers citing papers by Yumin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Wu. The network helps show where Yumin Wu may publish in the future.

Co-authorship network of co-authors of Yumin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yumin Wu. A scholar is included among the top collaborators of Yumin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumin Wu. Yumin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Hao, Sisi Ling, Quguang Li, et al.. (2025). Manganese Ions Chelated Tumosomes as Autologous Cancer Nanovaccines for Effective Suppression of Postsurgical Tumor Relapse. ACS Nano. 19(6). 5979–5994. 1 indexed citations
2.
Liu, Juan, Xiufeng Han, Le Liu, et al.. (2025). FTY720 alleviates HBV-mediated inflammatory liver injury through a dual role of inhibiting lymphocyte trafficking and viral replication. International Immunopharmacology. 153. 114495–114495. 1 indexed citations
3.
Wu, Yumin, et al.. (2024). Ginsenosides, salidroside, and syringin complex exhibits anti-fatigue in exhaustive exercise rats. International Journal of Medical Sciences. 22(1). 17–26. 3 indexed citations
4.
Wu, Yumin, et al.. (2024). Application of 3D-printed resin guides for the removal of molar fiber posts. Journal of Dentistry. 153. 105462–105462.
5.
Wu, Yumin, Bo Liu, Yifan Yan, et al.. (2024). Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy. Nature Communications. 15(1). 10503–10503. 11 indexed citations
6.
Wu, Yumin, Quguang Li, Yifan Yan, et al.. (2024). Gel-mediated recruitment of conventional type 1 dendritic cells potentiates the therapeutic effects of radiotherapy. Biomaterials. 305. 122470–122470. 7 indexed citations
8.
Guo, Hui, et al.. (2024). Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity. Cancer Immunology Immunotherapy. 73(4). 65–65. 12 indexed citations
9.
Li, Maoyi, Nanhui Liu, Jiafei Zhu, et al.. (2024). Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Biomaterials. 309. 122584–122584. 41 indexed citations
10.
Guo, Hui, et al.. (2024). Manganese-mediated potentiation of antitumor immune responses by enhancing KLRG1+ Macrophage function. International Immunopharmacology. 141. 112951–112951.
11.
Liu, Dongmei, et al.. (2023). Biocompatible dual network bovine serum albumin-loaded hydrogel-accelerates wound healing. European Polymer Journal. 185. 111820–111820. 13 indexed citations
12.
Yu, Hao, Yumin Wu, Ziliang Dong, et al.. (2023). CaCO3 based proton nanosponge to potentiate immune checkpoint blockade therapy by synergistically reversing tumor immunosuppression. Chemical Engineering Journal. 462. 142206–142206. 21 indexed citations
13.
Liu, Nanhui, Junjie Zhu, Wenjun Zhu, et al.. (2023). X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy. Advanced Materials. 35(29). e2302220–e2302220. 77 indexed citations
14.
Gao, Yuan, Tao Wang, Ying Cheng, et al.. (2023). Melatonin ameliorates neurological deficits through MT2/IL-33/ferritin H signaling-mediated inhibition of neuroinflammation and ferroptosis after traumatic brain injury. Free Radical Biology and Medicine. 199. 97–112. 35 indexed citations
15.
Chen, Yanru, et al.. (2023). A Nomogram for Predicting Extubation Failure in Preterm Infants with Gestational Age Less than 29 Weeks. Neonatology. 120(4). 424–433. 2 indexed citations
16.
Gu, Jin, Xinyu Yang, Yukang Yuan, et al.. (2022). Ubiquitin-specific protease 24 promotes EV71 infection by restricting K63-linked polyubiquitination of TBK1. Virologica Sinica. 38(1). 75–83. 9 indexed citations
17.
Wu, Yumin, et al.. (2020). Rapid selection of a novel GLP-1/GIP dual receptor agonist with prolonged glycemic control and weight loss in rodent animals. Life Sciences. 257. 118025–118025. 6 indexed citations
18.
Wu, Yumin, Shi Wei-feng, Honghai Wang, et al.. (2020). <p>Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4<sup>+</sup>T Response</p>. International Journal of Nanomedicine. Volume 15. 9745–9758. 14 indexed citations
20.
Su, Zhaoliang, Qingli Bie, Pan Zhang, et al.. (2016). Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice. Molecular Medicine Reports. 13(6). 5230–5240. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026